Sanofi has entered exclusive negotiations with private equity firm Clayton, Dubilier & Rice (CD&R) regarding the sale of its consumer health unit, Opella. This development comes as the French government seeks assurances on job security amid ongoing economic challenges. Emmanuel Macron's administration is grappling with rising public discontent and economic pressures, including a significant deficit crisis. Analysts suggest that the financial situation could threaten Macron's position, with some arguing that the National Rally (RN) party could capitalize on this instability. The broader context includes concerns over France's high taxation and potential cutbacks that may further impact economic growth.